Heron Therapeutics: Impending Catalysts Makes It A Must Watch!
Heron Therapeutics, Inc. (NASDAQ: HRTX) has a major upcoming catalyst in the form of the upcoming Prescription Drug User Fee Act (PDUFA) date...
Coverage
- All
- Beauty
- Biotechnology
- Cannabis
- Communications
- Education
- Energy
- Entertainment
- Environment
- ETFs
- Finance
- Fitness
- Food and Beverage
- Healthcare
- Hospitality
- Insider Trading
- Investing Ideas
- Macro
- Market Insight
- Miscellaneous
- Power
- Real Estate
- Retail
- Sectors
- Security
- Startups
- Technologies
- Trending
- Uncategorized
Heska Corporation – The Cat’s Meow!
Heska Corporation (NASDAQ: HSKA) is a premier veterinary diagnostic and specialty products manufacturer with presence in major markets such as the United States,...
4 Biotech Companies for your Investment Watchlist!
Biotech Companies continue to show resurgence even in these challenging times, with more and more companies persevering with bringing their clinical candidates to...
Is Brooklyn ImmunoTherapeutics the Next GameStop in the making?
Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) has been having a fantastic run at the stock market this year, with its shares rising by almost...
SunHydrogen – A potential gamechanger in renewable energy
SunHydrogen, Inc. (OTCPK: HYSR) formerly known as HyperSolar Inc, is a pioneer in the production of nanoparticle systems that are not only powered...
Upcoming Catalysts Make Tonix Pharmaceuticals a Must Watch!
The Company is developing a pipeline of candidates focused on small molecules and biologics that can treat central nervous system (CNS) and immunology...
2 Meme Stocks with Growth potential!
GameStop Corp. (NYSE: GME), a stock that was struggling after hitting historic lows of under $4 per unit since the past two years,...
Will Evelo Biosciences Differentiated SINTAX approach pay off?
Evelo Biosciences, Inc. (NASDAQ: EVLO) is focused on developing innovative oral biologics that target cells in the intestines for the treatment of a...
Can Humanigen’s lenzilumab Prove to be a Gamechanger for the Company?
Humanigen, Inc. (NASDAQ: HGEN) is a clinical-stage biopharmaceutical Company that is focused on creating a portfolio of monoclonal antibodies targeting immunology and immune-oncology...
